HLA-DRB1 and viral infectious disease: In contrast, HLA-DRB1 overall repertoire did not seem to be associated with either COVID-19 susceptibility or severity (Figures 3, 4), which is consistent with previous studies (15, 54) and compatible with the fact that HLA Class II molecules are less directly involved with initial reactions against viral infections.